Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers

Inclusion Criteria: * Chinese healthy male volunteers as determined by result of screening * Written informed consent in accordance with Good Clinical Practice (GCP) * Age \>= 18 and \<= 40 years * Broca \> - 20% and \< + 20% Exclusion Criteria: * Any finding of the medical examination (blood pressure, pulse rate and Electrocardiogram (ECG) deviating from normal and of clinical relevance * Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorder * Surgery of the gastro-intestinal tract (except appendectomy) * Diseases of the central nervous system (such as epilepsy) or psychiatric disorders * Chronic or relevant acute infections * Hypersensitivity to Mobic and/or non-steroidal anti-inflammatory drugs * Intake any drugs within 1 month before randomization * Participation in another trial with an investigational drug within the last 2 month or during the trial * Smokers ( \>= 10 cigarettes or \>= 3 cigars or \>= 3 pipes/day) or inability to refrain from smoking on study days * Alcohol or drug abuse * Blood donation within the last 1 month * Excessive physical activities within the last 5 days * History of hemorrhagic diatheses * History of gastro-intestinal ulcer, perforation or bleeding * History of bronchial asthma